PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Sep-2021 Takeda fait le point sur l’essai PANTHER (Pevonedistat-3001) de Phase 3 Businesswire
02-Sep-2021 Global Cancer Biological Therapy Market to 2026 - Rising Awareness on Cancer Coupled With Increased Healthcare Expenditure is Driving Growth - ResearchAndMarkets.com Businesswire
02-Sep-2021 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drugs Pipeline Landscape Report 2021 - ResearchAndMarkets.com Businesswire
02-Sep-2021 Takeda brinda nueva información sobre su ensayo PANTHER (Pevonedistat-3001) de fase 3 Businesswire
02-Sep-2021 Takeda informiert über den aktuellen Stand der Phase-3-Studie PANTHER (Pevonedistat-3001) Businesswire
02-Sep-2021 Takeda fornece atualização sobre Fase 3 do estudo PANTHER (Pevonedistat-3001) Businesswire
02-Sep-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
02-Sep-2021 Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment Businesswire
02-Sep-2021 Riassunto: Takeda fornisce un aggiornamento sullo studio clinico PANTHER (pevonedistat-3001) di fase 3 Businesswire
02-Sep-2021 Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market Businesswire
02-Sep-2021 Dr Reddy’s Laboratories Canada annonce le lancement de Reddy-Lénalidomide, l’un des premiers médicaments génériques du genre pour le marché canadien Businesswire
02-Sep-2021 Polaryx Therapeutics Receives FDA Orphan Drug Designation for PLX-200 to Treat Krabbe Disease Newswire
01-Sep-2021 U.S. FDA Grants BRUKINSA® (Zanubrutinib) Approval in Waldenström’s Macroglobulinemia Businesswire
01-Sep-2021 DTRT Health Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering Businesswire
01-Sep-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Yalla Group Limited (YALA) on Behalf of Investors Businesswire
01-Sep-2021 Eagle Pharmaceuticals to Present at September Healthcare Conferences Businesswire
01-Sep-2021 Moderna Announces Submission of Initial Data to U.S. FDA for Its COVID-19 Vaccine Booster Businesswire
01-Sep-2021 Takeda Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial Businesswire
01-Sep-2021 Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in September Businesswire
01-Sep-2021 Apyx Medical Corporation to Participate in the Colliers Securities 2021 Institutional Investor Conference Businesswire